Compare NHI & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NHI | PBH |
|---|---|---|
| Founded | 1991 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 2.8B |
| IPO Year | 1991 | 2005 |
| Metric | NHI | PBH |
|---|---|---|
| Price | $77.62 | $61.48 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 5 |
| Target Price | $84.80 | ★ $86.40 |
| AVG Volume (30 Days) | 176.2K | ★ 429.1K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | ★ 4.74% | N/A |
| EPS Growth | ★ 8.88 | N/A |
| EPS | 3.17 | ★ 4.04 |
| Revenue | $357,572,000.00 | ★ $1,110,479,000.00 |
| Revenue This Year | $5.50 | N/A |
| Revenue Next Year | $11.38 | $2.50 |
| P/E Ratio | $24.49 | ★ $15.19 |
| Revenue Growth | ★ 8.40 | N/A |
| 52 Week Low | $65.13 | $57.25 |
| 52 Week High | $80.56 | $90.04 |
| Indicator | NHI | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 48.92 | 56.45 |
| Support Level | $75.85 | $59.52 |
| Resistance Level | $79.65 | $62.14 |
| Average True Range (ATR) | 1.47 | 1.55 |
| MACD | -0.32 | 0.32 |
| Stochastic Oscillator | 33.55 | 86.90 |
National Health Investors Inc is a housing and medical facility REIT. The company operates through two reportable segments, i.e., Real Estate Investments and Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment, which generates maximum revenue, consists of real estate investments and leases, mortgages, and other notes receivables in independent living facilities, assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilities, and a hospital. The SHOP segment is comprised of two ventures that own the operations of independent living facilities. The company's revenues are derived in the form of rental income, mortgage and other notes receivable interest income, and resident fees and services.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.